Stock listing
10V Stock Price, News, Filings & Events — Immunic, Inc.
Selected listing: 10V · TRADEGATE · EUR · DE
This page tracks Immunic, Inc.'s 10V:TRADEGATE listing on TRADEGATE in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 10V:TRADEGATE. 10V:TRADEGATE is the stock-level entry point for investors researching Immunic, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- 10V:TRADEGATE
- Asset type
- Stock
- Market cap
- $210.1M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- TRADEGATE
- Currency
- EUR
Immunic, Inc. 10V:TRADEGATE stock context
This page tracks Immunic, Inc.'s 10V:TRADEGATE listing on TRADEGATE in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 10V:TRADEGATE. 10V:TRADEGATE is the stock-level entry point for investors researching Immunic, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Immunic, Inc.
Immunic Appoints Chitrang Davé as Chief Data and Digital Officer
September 1, 2026
Immunic, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 11, 2026
Immunic to Participate in Investor Conferences in July
July 9, 2026
Immunic to Participate in Investor, Industry and Scientific Conferences in June
June 10, 2026
Immunic to Present Additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the CMSC Annual Meeting 2026, Reinforcing Its Poten...
May 28, 2026
Immunic, Inc. earnings calls
Immunic, Inc. (IMUX) Q3 2024 Earnings Call
November 7, 2024 · Replay with transcript and chapters
Immunic, Inc. (IMUX) Q2 2024 Earnings Call
August 8, 2024 · Replay with transcript and chapters
Immunic, Inc. (IMUX) Q1 2024 Earnings Call
May 8, 2024 · Replay with transcript and chapters
Immunic, Inc. (IMUX) Q4 2023 Earnings Call
February 22, 2024 · Replay with transcript and chapters
Immunic, Inc. (IMUX) Q3 2023 Earnings Call
November 14, 2023 · Replay with transcript and chapters
Immunic, Inc. (IMUX) Q2 2023 Earnings Call
August 3, 2023 · Replay with transcript and chapters
Research Immunic, Inc.
Immunic, Inc. investor report
Review AI stock analysis and investor report context for 10V:TRADEGATE.
Immunic, Inc. company profile
View the public company page for Immunic, Inc. on 6ix.
Immunic, Inc. news
Read company news and market updates connected to Immunic, Inc..
Immunic, Inc. investor events
Find investor webinars, events, and replay context for Immunic, Inc..
Alternate listings
IMUX:NASDAQ
US · USD
Alternate listing for Immunic, Inc.; the primary context on this page is 10V:TRADEGATE.
IMUX:BOATS
US · USD
Alternate listing for Immunic, Inc.; the primary context on this page is 10V:TRADEGATE.
10V:FWB
DE · EUR
Alternate listing for Immunic, Inc.; the primary context on this page is 10V:TRADEGATE.
10V:GETTEX
DE · EUR
Alternate listing for Immunic, Inc.; the primary context on this page is 10V:TRADEGATE.
A428WY:LSX
DE · EUR
Alternate listing for Immunic, Inc.; the primary context on this page is 10V:TRADEGATE.
A428WY:LS
DE · EUR
Alternate listing for Immunic, Inc.; the primary context on this page is 10V:TRADEGATE.
10V:MUN
DE · EUR
Alternate listing for Immunic, Inc.; the primary context on this page is 10V:TRADEGATE.